Answers are grounded in this paper and cite their sources.
Pharmacogenetics represents an emerging approach for personalized medicine in heart failure, though its clinical application remains limited compared to other therapeutic areas.
Personalized medicine is the concept of patient care becoming individualized based on distinctive characteristics. Pharmacogenetics is an application of personalized medicine, which may allow us to predict response to treatment based on an individual's genetic makeup. While several therapeutic areas have made significant advances in using pharmacogenetics to tailor therapies, it is not yet widely used in the treatment of heart failure. In this review, we summarize some of the emerging data on the use of pharmacogenetics in heart failure therapies.
No takes yet. Share an insight, caveat, or question.
Fiuzat et al. (2009) conducted a review in Heart failure. Pharmacogenetics was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: